Observational studyClinical drug investigation2024

The Early Access and the Potential Cost Savings by the Compassionate Use of Onco-haematological Drugs: Results from the Italian Study Compass-O.

Irene Dell'Anno et al.PubMed ↗Publisher ↗

No numbers read from the abstract.